IS7076A - Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni - Google Patents

Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni

Info

Publication number: IS7076A
Authority: IS; Iceland
Prior art keywords: vaccination; drug; single dose; mycoplasma hyopneumoniae; therapeutic use
Prior art date: 2001-07-02

Application number

IS7076A

Other languages

English (en)

Inventor

Lee Keich Robin

Grace Sabbadini Lisa

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-02

Filing date

2003-12-15

Publication date

2003-12-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23168589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS7076(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-12-15 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

2003-12-15 Publication of IS7076A publication Critical patent/IS7076A/is

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/87—Mycoplasma

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Immunology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Mycology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

IS7076A 2001-07-02 2003-12-15 Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni IS7076A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US30263601P	2001-07-02	2001-07-02
PCT/IB2002/002121 WO2003003941A2 (en)	2001-07-02	2002-06-07	One dose vaccination with mycoplasma hyopneumoniae

Publications (1)

Publication Number	Publication Date
IS7076A true IS7076A (is)	2003-12-15

Family

ID=23168589

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7076A IS7076A (is)	2001-07-02	2003-12-15	Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni

Country Status (42)

Country	Link
US (3)	US6846477B2 (is)
EP (3)	EP2027873B8 (is)
JP (1)	JP2005515162A (is)
KR (1)	KR20040030785A (is)
CN (3)	CN101524532B (is)
AP (1)	AP2003002937A0 (is)
AR (1)	AR034678A1 (is)
AT (1)	ATE412426T2 (is)
AU (1)	AU2002309109B2 (is)
BG (1)	BG66481B1 (is)
BR (1)	BR0210804A (is)
CA (1)	CA2451626C (is)
CY (1)	CY1108749T1 (is)
CZ (1)	CZ305781B6 (is)
DE (1)	DE60229666D1 (is)
DK (3)	DK2027873T3 (is)
DO (1)	DOP2002000431A (is)
EA (1)	EA009901B1 (is)
ES (3)	ES2312580T5 (is)
GT (1)	GT200200138A (is)
HK (1)	HK1207584A1 (is)
HR (1)	HRP20031079A2 (is)
HU (1)	HU230246B1 (is)
IL (1)	IL159349A0 (is)
IS (1)	IS7076A (is)
MA (1)	MA27047A1 (is)
MX (1)	MXPA03011599A (is)
NO (1)	NO342654B1 (is)
NZ (1)	NZ530106A (is)
OA (1)	OA12638A (is)
PA (1)	PA8549701A1 (is)
PE (1)	PE20030285A1 (is)
PL (1)	PL209773B1 (is)
PT (3)	PT1474067E (is)
SK (1)	SK288010B6 (is)
TN (1)	TNSN03155A1 (is)
TW (1)	TWI329514B (is)
UA (1)	UA78707C2 (is)
UY (1)	UY27366A1 (is)
WO (1)	WO2003003941A2 (is)
YU (1)	YU102203A (is)
ZA (1)	ZA200309698B (is)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY129765A (en) *	2000-12-19	2007-04-30	Wyeth Corp	Improved mycoplasma hyopneumoniae bacterin vaccine
WO2006056841A1 (en) *	2004-11-24	2006-06-01	Pharmacia & Upjohn Company Llc	Multiple-strain mycoplasma hyopneumoniae vaccines
US7700285B1 (en)	2005-12-29	2010-04-20	Boehringer Ingelheim Vetmedica, Inc.	PCV2 immunogenic compositions and methods of producing such compositions
US7833707B2 (en)	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
UA95602C2 (ru)	2004-12-30	2011-08-25	Берингер Ингельхейм Ветмедика, Инк.	Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8834891B2 (en)	2005-03-14	2014-09-16	Boehringer Ingelheim Vetmedica, Inc.	Immunogenic compositions comprising Lawsonia intracellularis
PL2371383T3 (pl)	2005-12-29	2016-01-29	Boehringer Ingelheim Vetmedica Inc	Zastosowanie kompozycji immunogennej do zmniejszania objawów klinicznych u świń
US20080226669A1 (en)	2005-12-29	2008-09-18	Boehringer Ingelheim Vetmedica, Inc.	Multivalent pcv2 immunogenic compositions and methods of producing such compositions
CA2644195A1 (en) *	2006-03-03	2007-09-13	Merial Limited	Mycoplasma hyopneumoniae vaccine
WO2008064299A2 (en) *	2006-11-22	2008-05-29	Boehringer Ingelheim Vetmedica, Inc.	Methods of reducing porcine circovirus-associated disease outbreaks
WO2008073464A2 (en)	2006-12-11	2008-06-19	Boehringer Ingelheim Vetmedica, Inc.	Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
ES2625460T5 (es)	2006-12-15	2020-11-04	Boehringer Ingelheim Animal Health Usa Inc	Tratamiento de cerdos seropositivos en anticuerpo anti-PCV2 con antígeno de PCV2
EP1941903A1 (en)	2007-01-03	2008-07-09	Boehringer Ingelheim Vetmedica Gmbh	Prophylaxis and treatment of PRDC
EP1958644A1 (en)	2007-02-13	2008-08-20	Boehringer Ingelheim Vetmedica Gmbh	Prevention and treatment of sub-clinical pcvd
US7829274B2 (en)	2007-09-04	2010-11-09	Boehringer Ingelheim Vetmedica, Inc.	Reduction of concomitant infections in pigs by the use of PCV2 antigen
BRPI0820341B1 (pt)	2007-11-06	2021-11-09	Zoetis Services Llc	Composição imunogênica para uso na proteção de um animal contra uma doença associada a uma cepa virulenta de mycoplasma hyopneumoniae
BRPI0821456A2 (pt) *	2007-12-31	2015-06-16	Boehring Ingelheim Vetmedica Inc	Partícula similar à pcv2 orf2 com inserção de aminoácido estranho
CN101236206B (zh) *	2008-01-17	2014-10-15	中国兽医药品监察所	一种猪肺炎支原体重组抗原elisa检测试剂盒
EP2242511A4 (en)	2008-01-23	2012-10-24	Boehringer Ingelheim Vetmed	IMMUNOGENIC COMPOSITIONS OF MYCOPLASMA HYOPNEUMONIAE PCV2, AND METHODS FOR PRODUCING SUCH COMPOSITIONS
US8444989B1 (en) *	2008-04-18	2013-05-21	Boehringer Ingelheim Vetmedica Gmbh	One dose vaccination against mycoplasma infections of pigs
CN102076358B (zh)	2008-06-27	2016-08-17	硕腾有限责任公司	新颖的佐剂组合物
EP2438926B1 (en)	2009-06-04	2016-03-23	M Bio Technology Inc.	Vaccine for mycoplasma infection
TWI627281B (zh)	2009-09-02	2018-06-21	百靈佳殷格翰家畜藥品公司	降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
CA2793959C (en)	2010-03-25	2019-06-04	Oregon Health & Science University	Cmv glycoproteins and recombinant vectors
WO2011141443A1 (en)	2010-05-11	2011-11-17	Intervet International B.V.	Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies
EP4324526A3 (en) *	2010-07-26	2024-05-22	Qu Biologics Inc.	Immunogenic anti-inflammatory compositions
US8546149B2 (en)	2010-08-27	2013-10-01	Intervet Inc.	Potency test for vaccine formulations
CN103154737B (zh) *	2010-08-27	2015-07-15	英特维特国际股份有限公司	疫苗制剂的效价测试
DK2691530T3 (en)	2011-06-10	2018-05-22	Univ Oregon Health & Science	CMV GLYCOPROTEIN AND RECOMBINANT VECTORS
BR112014022067B1 (pt)	2012-03-07	2022-05-31	Ceva Sante Animale	Composição compreendendo antígeno e lipopolissacarídeo
UA114504C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en)	2012-04-04	2015-09-01	Zoetis Services Llc	Mycoplasma hyopneumoniae vaccine
PL2938747T3 (pl)	2012-12-28	2019-11-29	Boehringer Ingelheim Vetmedica Gmbh	Sposób wytwarzania szczepionki przeciwko mykoplazmie
CA2896293C (en)	2012-12-28	2023-11-07	Boehringer Ingelheim Vetmedica Gmbh	Immunogenic composition comprising mycoplasma antigens
KR101775435B1 (ko) *	2013-02-05	2017-09-06	애그리컬쳐럴 테크놀로지 리서치 인스티튜트	항-마이코플라즈마 에스피피. 아단위 백신
CN104338125A (zh) *	2013-07-29	2015-02-11	普莱柯生物工程股份有限公司	一种猪肺炎支原体抗原在预防和治疗猪呼吸道疾病综合征方面的应用
RU2730011C2 (ru)	2013-09-19	2020-08-14	Зоэтис Сервисиз Ллс	Адъюванты на масляной основе
DK3052516T3 (da)	2013-10-02	2020-03-23	Boehringer Ingelheim Animal Health Usa Inc	PCV2-ORF2-proteinvariant og viruslignende partikler sammensat deraf
KR101842081B1 (ko)	2013-11-21	2018-03-26	애그리컬쳐럴 테크놀로지 리서치 인스티튜트	마이코플라즈마 에스피피 감염을 예방하기 위한 조성물
CN105012948B (zh) *	2014-04-18	2019-07-30	普莱柯生物工程股份有限公司	一种疫苗组合物及其应用
CN104248753B (zh) *	2014-05-15	2017-07-28	普莱柯生物工程股份有限公司	一种疫苗组合物及其应用
BR102014014727B1 (pt) *	2014-06-16	2018-04-03	Ouro Fino Saúde Animal Ltda	COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, GENE SINTÉTICO CODIFICANTE DO COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, COMPOSIÇÃO ANTIGÊNICA, PROCESSO DE OBTENÇÃO DE UM COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae
US9814769B2 (en)	2014-09-30	2017-11-14	Qatar University	Vaccines against pathogenic Escherichia coli and methods of using the same
FI3244920T3 (fi)	2015-01-16	2023-08-04	Zoetis Services Llc	Suu- ja sorkkatautirokote
KR20160099223A (ko) *	2015-02-12	2016-08-22	강원대학교산학협력단	마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
KR101846478B1 (ko) *	2016-08-12	2018-04-06	주식회사 이노백	재조합 단백질을 포함하는 돼지 마이코플라즈마 감염 예방용 백신 조성물
RU2668799C1 (ru) *	2017-09-08	2018-10-02	Эгрикалчурал Текнолоджи Рисерч Инститьют	Субъединичная вакцина против mycoplasma spp.
CN108101969A (zh) *	2017-11-13	2018-06-01	南京大爻网络科技有限公司	一种与猪支原体肺炎相关的抗原及其应用
RU2695679C1 (ru) *	2018-09-11	2019-07-25	Эгрикалчурал Текнолоджи Рисерч Инститьют	Субъединичная вакцина против mycoplasma spp.
RU2759427C2 (ru) *	2019-07-08	2021-11-12	Эгрикалчурал Текнолоджи Рисерч Инститьют	Субъединичная вакцина против mycoplasma spp
CN117305192A (zh) *	2023-12-01	2023-12-29	北京瑞阳瑞泰生物科技有限公司	一种猪肺炎支原体rt02株、疫苗组合物及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0283840A3 (en) *	1987-03-26	1989-08-09	Ml Technology Ventures, L.P.	Mycoplasma hyopneumoniae antigen and uses therefor
US5252328A (en)	1987-03-26	1993-10-12	Martin Marietta Energy Systems, Inc.	Mycoplasma hyopneumoniae antigen and uses therefor
EP0307976B1 (en)	1987-09-18	1993-06-23	Akzo Nobel N.V.	Mycoplasma vaccine
CA2078131A1 (en)	1990-04-02	1991-10-03	Jerry M. Kuner	Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals
CA2082155C (en)	1990-05-29	2008-04-15	Krishnaswamy I. Dayalu	Swine pneumonia vaccine and method of preparation
US6113916A (en) *	1990-05-29	2000-09-05	American Cyanamid Company	Method of enhancing cell mediated immune responses
US5565205A (en) *	1990-08-16	1996-10-15	Solvay Animal Health, Inc.	Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
EP0475185A1 (en)	1990-08-27	1992-03-18	Nippon Flour Mills Co., Ltd.	DNA's encoding surface antigen of mycoplasma hyopneumoniae, DNA fragments for primer, recombinant antigenic peptides and diagnostic method of mycoplasmal pneumoniae of swine using same
US5338543A (en) *	1992-02-27	1994-08-16	Ambico, Inc.	Thimerosal inactivated mycoplasma hyopneumoniae vaccine
DK0839050T3 (da)	1992-09-28	2004-10-25	Wyeth Corp	Fremgangsmåde til at forstærke celleformidlede immunreaktioner
US5530874A (en)	1993-02-02	1996-06-25	3Com Corporation	Network adapter with an indication signal mask and an interrupt signal mask
WO1995009870A1 (en)	1993-10-07	1995-04-13	Iowa State University Research Foundation, Inc.	Characterization of mycoplasma hyopneumoniae adhesins
DE69518316T2 (de)	1994-05-10	2001-03-29	American Home Products Corp., Madison	Modifizierter,verbesserter,lebender brsv impfstoff
US5788962A (en)	1995-01-17	1998-08-04	The Curators Of The University Of Missouri	DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures
AUPN178995A0 (en) *	1995-03-16	1995-04-13	University Of Melbourne, The	Antigen composition
BR9713312B1 (pt)	1996-09-30	2009-08-11		preparado de vacina para uso veterinário útil para produzir imunidade ativa contra uma doença bacteriana ou protozoária.
EP0846468B1 (en)	1996-12-05	2004-06-09	Akzo Nobel N.V.	Non-virulent mycoplasma synoviae and vaccine thereof
JP2001523481A (ja)	1997-11-26	2001-11-27	アイオワステイトユニヴァーシティリサーチファウンデーションインコーポレイテッド	組換えｈｙｏ肺炎マイコプラズマワクチン
AU6128900A (en) *	1999-09-29	2001-04-05	Pfizer Products Inc.	Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof
US6585981B1 (en) *	2000-07-27	2003-07-01	Regents Of The University Of Minnesota	Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
UA114504C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs

2002
- 2002-06-07 TN TNPCT/IB2002/002121A patent/TNSN03155A1/fr unknown
- 2002-06-07 DK DK08167761.9T patent/DK2027873T3/en active
- 2002-06-07 EP EP08167761.9A patent/EP2027873B8/en not_active Expired - Lifetime
- 2002-06-07 EP EP02735755.7A patent/EP1474067B2/en not_active Expired - Lifetime
- 2002-06-07 PL PL373367A patent/PL209773B1/pl unknown
- 2002-06-07 ES ES02735755.7T patent/ES2312580T5/es not_active Expired - Lifetime
- 2002-06-07 CN CN200810186079.6A patent/CN101524532B/zh not_active Expired - Lifetime
- 2002-06-07 IL IL15934902A patent/IL159349A0/xx unknown
- 2002-06-07 PT PT02735755T patent/PT1474067E/pt unknown
- 2002-06-07 JP JP2003509957A patent/JP2005515162A/ja active Pending
- 2002-06-07 AT AT02735755T patent/ATE412426T2/de active
- 2002-06-07 WO PCT/IB2002/002121 patent/WO2003003941A2/en not_active Ceased
- 2002-06-07 DE DE60229666T patent/DE60229666D1/de not_active Expired - Lifetime
- 2002-06-07 CN CN028133447A patent/CN1551781B/zh not_active Expired - Lifetime
- 2002-06-07 HU HU0400434A patent/HU230246B1/hu unknown
- 2002-06-07 AP APAP/P/2003/002937A patent/AP2003002937A0/en unknown
- 2002-06-07 MX MXPA03011599A patent/MXPA03011599A/es active IP Right Grant
- 2002-06-07 AU AU2002309109A patent/AU2002309109B2/en not_active Expired
- 2002-06-07 YU YU102203A patent/YU102203A/sh unknown
- 2002-06-07 HR HR20031079A patent/HRP20031079A2/hr not_active Application Discontinuation
- 2002-06-07 NZ NZ530106A patent/NZ530106A/en not_active IP Right Cessation
- 2002-06-07 SK SK1579-2003A patent/SK288010B6/sk unknown
- 2002-06-07 PT PT14182639T patent/PT2842569T/pt unknown
- 2002-06-07 EP EP14182639.6A patent/EP2842569B1/en not_active Revoked
- 2002-06-07 PT PT81677619T patent/PT2027873E/pt unknown
- 2002-06-07 OA OA1200300344A patent/OA12638A/en unknown
- 2002-06-07 DK DK02735755.7T patent/DK1474067T4/en active
- 2002-06-07 CZ CZ2003-3466A patent/CZ305781B6/cs not_active IP Right Cessation
- 2002-06-07 DK DK14182639.6T patent/DK2842569T3/da active
- 2002-06-07 KR KR10-2004-7000044A patent/KR20040030785A/ko not_active Ceased
- 2002-06-07 ES ES08167761.9T patent/ES2550458T3/es not_active Expired - Lifetime
- 2002-06-07 EA EA200301323A patent/EA009901B1/ru not_active IP Right Cessation
- 2002-06-07 CA CA2451626A patent/CA2451626C/en not_active Expired - Lifetime
- 2002-06-07 ES ES14182639T patent/ES2729579T3/es not_active Expired - Lifetime
- 2002-06-07 BR BR0210804-6A patent/BR0210804A/pt not_active Application Discontinuation
- 2002-06-07 CN CN201210389058.0A patent/CN102872456B/zh not_active Expired - Lifetime
- 2002-06-19 US US10/174,701 patent/US6846477B2/en not_active Ceased
- 2002-06-26 DO DO2002000431A patent/DOP2002000431A/es unknown
- 2002-06-26 TW TW091114057A patent/TWI329514B/zh not_active IP Right Cessation
- 2002-07-01 UY UY27366A patent/UY27366A1/es not_active Application Discontinuation
- 2002-07-01 AR ARP020102479A patent/AR034678A1/es not_active Application Discontinuation
- 2002-07-01 PE PE2002000593A patent/PE20030285A1/es not_active Application Discontinuation
- 2002-07-02 GT GT200200138A patent/GT200200138A/es unknown
- 2002-07-02 PA PA20028549701A patent/PA8549701A1/es unknown
- 2002-07-06 UA UA20031213200A patent/UA78707C2/uk unknown
2003
- 2003-12-12 ZA ZA2003/09698A patent/ZA200309698B/en unknown
- 2003-12-15 IS IS7076A patent/IS7076A/is unknown
- 2003-12-22 NO NO20035762A patent/NO342654B1/no not_active IP Right Cessation
- 2003-12-31 MA MA27468A patent/MA27047A1/fr unknown
2004
- 2004-01-26 BG BG108546A patent/BG66481B1/bg unknown
- 2004-08-12 US US10/917,130 patent/US20050013823A1/en not_active Abandoned
2009
- 2009-01-16 CY CY20091100059T patent/CY1108749T1/el unknown
2012
- 2012-03-02 US US13/411,232 patent/USRE44399E1/en not_active Expired - Lifetime
2015
- 2015-08-27 HK HK15108334.1A patent/HK1207584A1/en unknown

Also Published As

Publication number	Publication date
BG108546A (bg)	2005-02-28
IL159349A0 (en)	2004-06-01
HUP0400434A2 (en)	2007-08-28
PL209773B1 (pl)	2011-10-31
CA2451626C (en)	2011-05-31
ES2729579T3 (es)	2019-11-04
NO20035762L (no)	2004-02-02
EA200301323A1 (ru)	2005-06-30
CN102872456A (zh)	2013-01-16
AU2002309109B2 (en)	2007-12-13
HU230246B1 (hu)	2015-11-30
JP2005515162A (ja)	2005-05-26
WO2003003941A2 (en)	2003-01-16
HRP20031079A2 (en)	2005-10-31
PT2842569T (pt)	2019-06-17
ES2550458T3 (es)	2015-11-10
EP1474067A4 (en)	2005-08-10
ES2312580T3 (es)	2009-03-01
DK1474067T3 (da)	2008-12-08
BR0210804A (pt)	2005-05-03
NO342654B1 (no)	2018-06-25
ES2312580T5 (es)	2017-12-11
DOP2002000431A (es)	2003-01-15
KR20040030785A (ko)	2004-04-09
SK15792003A3 (sk)	2005-09-08
PA8549701A1 (es)	2003-01-24
UY27366A1 (es)	2003-04-30
HK1134900A1 (zh)	2010-05-20
OA12638A (en)	2006-06-15
SK288010B6 (sk)	2012-10-02
DE60229666D1 (de)	2008-12-11
CZ20033466A3 (cs)	2005-06-15
HK1068250A1 (en)	2005-04-29
EP2842569B1 (en)	2019-04-10
WO2003003941A3 (en)	2004-07-29
AP2003002937A0 (en)	2003-12-31
USRE44399E1 (en)	2013-07-30
PT1474067E (pt)	2008-11-14
EP1474067B1 (en)	2008-10-29
DK2842569T3 (da)	2019-05-20
CN102872456B (zh)	2016-01-20
TWI329514B (en)	2010-09-01
BG66481B1 (bg)	2015-02-27
CN1551781A (zh)	2004-12-01
EP2027873B8 (en)	2015-11-11
HK1207584A1 (en)	2016-02-05
GT200200138A (es)	2003-05-15
YU102203A (sh)	2006-05-25
CN1551781B (zh)	2013-01-02
CN101524532B (zh)	2014-03-19
EP2027873B1 (en)	2015-09-09
PL373367A1 (en)	2005-08-22
AR034678A1 (es)	2004-03-03
PT2027873E (pt)	2015-11-03
NZ530106A (en)	2007-06-29
CY1108749T1 (el)	2014-04-09
EP1474067B2 (en)	2017-08-16
US6846477B2 (en)	2005-01-25
CA2451626A1 (en)	2003-01-16
PE20030285A1 (es)	2003-03-27
UA78707C2 (en)	2007-04-25
ZA200309698B (en)	2014-04-30
EP1474067A2 (en)	2004-11-10
CZ305781B6 (cs)	2016-03-16
ATE412426T2 (de)	2008-11-15
EA009901B1 (ru)	2008-04-28
HK1180224A1 (zh)	2013-10-18
EP2027873A1 (en)	2009-02-25
MA27047A1 (fr)	2004-12-20
TNSN03155A1 (fr)	2005-12-23
US20050013823A1 (en)	2005-01-20
MXPA03011599A (es)	2005-03-07
EP2842569A1 (en)	2015-03-04
DK1474067T4 (en)	2017-10-16
CN101524532A (zh)	2009-09-09
US20030109473A1 (en)	2003-06-12
DK2027873T3 (en)	2015-11-09

Publication	Publication Date	Title
IS7076A (is)	2003-12-15	Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni
NO20053224D0 (no)	2005-07-01	Patient controlled drug administration device.
ATE282428T1 (de)	2004-12-15	Pharmazeutische dosierungsform von amorphem nilfenavir mesylat
NO20035298D0 (no)	2003-11-28	CDK-inhiberende pyrimider, deres fremstilling og deres anvendelse som legemidler
PT1605956E (pt)	2016-03-09	Administração de capsaicinóides para o tratamento da osteoartrite
NO20035773L (no)	2004-02-27	Ny konstruert superantigen for human terapi
IS7691A (is)	2005-02-09	Lyfjasamsetningar til að meðhöndla æxli
EE05581B1 (et)	2012-10-15	Aripiprasooli ravimlahus peroraalseks manustamiseks
DK1409065T3 (da)	2007-05-21	Oftalmisk medikamentafgivelsesanordning
IS8398A (is)	2006-04-05	Lyfjasamsetningar til að meðhöndla æxli
DE60308372D1 (de)	2006-10-26	Dosierungsverabreichungsvorrichtung
ZA200410229B (en)	2006-07-26	Administration of therapeutic viruses
DK1537096T3 (da)	2009-02-02	Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf
EP1423141A4 (en)	2005-08-03	VACCINE
IS7065A (is)	2003-12-05	Áætlun um lyfjaskammta við meðferð og lyfjasamsetningar til getnaðarvarna í neyð
DK1513836T3 (da)	2006-09-11	Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
DK1590321T3 (da)	2010-08-09	Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
DK1417189T3 (da)	2006-05-08	Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
DK1387838T3 (da)	2006-08-14	Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
DK1556382T3 (da)	2008-10-06	3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf
EE200300501A (et)	2003-12-15	Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid
DE60336999D1 (de)	2011-06-16	Melatonin enthaltende pharmazeutische formulierung
NO20033120D0 (no)	2003-07-08	2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
FR2820311B3 (fr)	2003-01-17	Distributeur de medicament portatif
IS2487B (is)	2008-12-15	Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á